Main Menu
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Overview
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Amgen Competitive Grants
Biosimilars
Clinical Trials
Overview
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support program
Investigator Sponsored Studies
Scientific Community Initiatives
Overview
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Overview
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Overview
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2021
Environment, Social and Governance Strategy
Healthy People
Overview
Access to Medicines
Health Equity
Healthy Society
Overview
Diversity, Inclusion and Belonging
Human Capital Management
Community Investment and Amgen Foundation
Supplier Diversity
Healthy Planet
Overview
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Overview
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Overview
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
Amgen Worldwide
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
About
Overview
Amgen History
Mission and Values
Leadership
Amgen Foundation
Awards and Accolades
How We Operate
Corporate Governance
Business Ethics and Compliance
Policies, Practices and Disclosures
Science
Overview
Research and Development Strategy
Human Data
AI & Data Science
Multispecifics & Other Modalities
Clinical Trial Innovation
Pipeline
Amgen Science Podcasts
Scientific Advisory Boards
Amgen Competitive Grants
Biosimilars
Clinical Trials
About Clinical Trials
Amgen Clinical Trials
Clinical Trial Diversity and Representation
Information for Healthcare Professionals
Clinical Trial Transparency, Data Sharing and Disclosure Practices
Clinical Out-of-Hours Support Program
Investigator Sponsored Studies
Scientific Community Initiatives
Educational Outreach Program
Postdoctoral Fellows Program
Scientific Conferences Program
Start-Up Network Program
Manufacturing
Innovation
Quality
Reliability
PRODUCTS
Overview
Medical Information
Counterfeit Drug Statement
Safety Data Sheets
Global Patient Safety
Who We Are
Our Commitment
What We Do
Adverse Event and Product Complaint Reporting
Responsibility
Overview
Environmental, Social & Governance Report 2021
Environment, Social and Governance Strategy
Healthy People
Access to Medicines
Health Equity
Healthy Society
Amgen Foundation and Community Investment
Diversity, Inclusion and Belonging
Human Capital Management
Supplier Diversity
Healthy Planet
Environmental Sustainability
Supplier Sustainability
A Healthy Amgen
Corporate Governance
Business Ethics and Compliance
Ethical Research
Patient Safety
Product Quality
Cybersecurity and Data Privacy
Reporting and Metrics
Summary of Data
CDP
Archived Reports
Stories
All Stories
Responsibility
People and Culture
Science and Innovation
Patients
Leadership
Popular Tags
COVID-19
Supporting Our Staff
Leveraging Our Science
Serving Our Communities
Newsroom
Partners
Investors
Careers
X
Home
>
Stories
>
All Stories
RESPONSIBILITY
02.05.2021
Inside Amgen’s Push for Greater Diversity in Clinical Trials
Through an internal program known as RISE (Representation in Clinical Research), Amgen is looking to create greater equity related to clinical trial diversity.
Read more
All Stories <i class="fa fa-angle-down"></i><i class="fa fa-angle-up"></i>
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
All
PATIENTS
RESPONSIBILITY
LEADERSHIP
SCIENCE & INNOVATION
PEOPLE & CULTURE
LEADERSHIP
03.23.2023
Three Amgen Leaders Honored for Furthering the Advancement of Women
SCIENCE & INNOVATION
03.17.2023
Amgen at ACC: A Bold Mission to Cut Heart Attacks and Strokes in Half by 2030
PATIENTS
03.13.2023
Impact
2
: Conversations on the Power of Shared Purpose in Public Health
RESPONSIBILITY
03.08.2023
Women Find Purpose – and Support – at Amgen
PATIENTS
03.02.2023
Cardiovascular Disease – A Public Health Crisis with Underutilized Solutions
PATIENTS
03.01.2023
The Air Between Us All Sparks Transparent Conversations About Asthma
SCIENCE & INNOVATION
02.27.2023
3D Tissue Models Mimic the Human Immune System to Inform Drug Development
RESPONSIBILITY
02.22.2023
Heart Study’s Goal: Better Understand and Serve the Underrepresented
SCIENCE & INNOVATION
02.21.2023
Amgen Origins: The Single Arm that Relieved Many Backs
RESPONSIBILITY
02.09.2023
Amgen Foundation Donates to Relief Efforts in Türkiye and Syria Following Earthquake
PATIENTS
02.07.2023
5 Things You Need to Know About Heart Attacks
PATIENTS
02.07.2023
8 Things to Know About Lipoprotein(a)
Load more
Loading...